3121 - 3130 of 8471 Results
Title
Year
-
OPENTitle: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2945End Page: 2950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28779Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688198Citation Count: 123
-
OPENTitle: Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1663End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212672Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212672?id=journal-of-parkinsons-disease%2Fjpd212672Citation Count: 30
-
OPENTitle: Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00892-7Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-021-00892-7Citation Count: 15
-
OPENTitle: Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.711358Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.711358/pdfCitation Count: 9
-
OPENTitle: RETRACTED ARTICLE: Facial expressions can detect Parkinson’s disease: preliminary evidence from videos collected onlineJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-021-00502-8Best OA location URL: https://www.nature.com/articles/s41746-021-00502-8.pdfCitation Count: 49
-
RESTRICTEDTitle: Could Soluble Amyloid Be Neuroprotective Rather Than Toxic?Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page: 1,17End Page: 19Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792796.54034.5fCitation Count: 0
- Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical Rating2021RESTRICTEDTitle: Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical RatingJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2962End Page: 2963Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28776Citation Count: 6
-
RESTRICTEDTitle: Neurodegenerative disorder diagnosis using support vector machine and Naive bayes algorithmsJournal Name: 2021 Third International Conference on Inventive Research in Computing Applications (ICIRCA)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/icirca51532.2021.9545021Citation Count: 0
-
RESTRICTEDTitle: New Questions About a Mysterious Neurologic Cluster in CanadaJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page: 1,20End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792776.14362.2bCitation Count: 0
- Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone2021RESTRICTEDTitle: Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicaponeJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 9Start Page: 1019End Page: 1033Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2021.1968298Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/14737175.2021.1968298?needAccess=trueCitation Count: 20